9th Circ. COVID 'Cure' Case Shows Perks Of Puffery Defense

By John MacGregor, Jason Rozbruch and Ryan Maloney (May 31, 2024, 5:40 PM EDT) -- On March 25, the U.S. Court of Appeals for the Ninth Circuit affirmed the dismissal of securities fraud claims against biopharmaceutical company Sorrento Therapeutics Inc., CEO Henry Ji and Vice President Mark Brunswick based on allegedly false and misleading statements about the company's potential COVID-19 cure.[1]...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!